BlackRock
HSCS icon

BlackRock’s Heart Test Laboratories HSCS Stock Holding History

BlackRock’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88K Buy
+750
New +$1.54K ﹤0.01% 5538

Other funds holding HSCS

TA
TFB Advisors Overland Park, Kansas $227M AUM 26.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TWM
Tradition Wealth Management Edina, Minnesota $1.64B AUM 26.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

BlackRock's HSCS Position: Q2 2026 in Review

BlackRock opened a new position in Heart Test Laboratories (HSCS) in Q2 2026: 750 shares worth $1.88K. The stake represents ﹤0.01% of the portfolio and ranks #5538 among its holdings.

16 funds tracked by Wall St. Rank hold HSCS as of Q2 2026.

  • BlackRock held 750 shares of Heart Test Laboratories worth $1.88K as of Q2 2026.
  • Heart Test Laboratories was a new BlackRock position in Q2 2026.
  • Heart Test Laboratories made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5538 holding.
  • 16 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.